These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10802271)

  • 41. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.
    Schwingl PJ; Ory HW; Visness CM
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):241-9. PubMed ID: 9914611
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of hormonal contraceptives on vitamin B12 level and the association of the latter with bone mineral density.
    Berenson AB; Rahman M
    Contraception; 2012 Nov; 86(5):481-7. PubMed ID: 22464408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hormonal contraception and bone metabolism: a systematic review.
    Nappi C; Bifulco G; Tommaselli GA; Gargano V; Di Carlo C
    Contraception; 2012 Dec; 86(6):606-21. PubMed ID: 22717184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of long-term postoperative oral contraceptive use for the prevention of endometrioma recurrence on bone mineral density in young women.
    Lee DY; Oh YK; Yoon BK; Choi D
    Gynecol Endocrinol; 2014 Oct; 30(10):751-4. PubMed ID: 24927075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
    Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R
    Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
    Falsetti L; Pasinetti E
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
    Rosenfeld WE; Doose DR; Walker SA; Nayak RK
    Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral contraceptives and bone mineral density in white and black women in CARDIA. Coronary Risk Development in Young Adults.
    Cobb KL; Kelsey JL; Sidney S; Ettinger B; Lewis CE
    Osteoporos Int; 2002 Nov; 13(11):893-900. PubMed ID: 12415437
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral contraceptive use by teenage women does not affect peak bone mass: a longitudinal study.
    Lloyd T; Taylor DS; Lin HM; Matthews AE; Eggli DF; Legro RS
    Fertil Steril; 2000 Oct; 74(4):734-8. PubMed ID: 11020515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel.
    Gaspard UJ; Dubois M; Gillain D; Franchimont P; Duvivier J
    Contraception; 1984 Apr; 29(4):305-18. PubMed ID: 6430638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF; Crook D; Devenport M; Wynn V
    Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
    Lopez LM; Chen M; Mullins S; Curtis KM; Helmerhorst FM
    Cochrane Database Syst Rev; 2012 Aug; (8):CD009849. PubMed ID: 22895991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone loss, contraception and lactation.
    Mehta S
    Acta Obstet Gynecol Scand; 1993 Apr; 72(3):148-56. PubMed ID: 8385847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.
    Kirkman RJ; Pedersen JH; Fioretti P; Roberts HE
    Contraception; 1994 Jan; 49(1):33-46. PubMed ID: 8137624
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Laboratory criteria for menopause in women using oral contraceptives.
    Creinin MD
    Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomized trial of three oral contraceptives: comparison of bleeding patterns by contraceptive types and steroid levels.
    Saleh WA; Burkman RT; Zacur HA; Kimball AW; Kwiterovich P; Bell WK
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1740-5; discussion 1745-7. PubMed ID: 8317516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hormonal contraception: benefits versus risks.
    Goldzieher JW
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1023-8. PubMed ID: 3674179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users.
    Brill K; Norpoth T; Schnitker J; Albring M
    Contraception; 1991 Feb; 43(2):101-10. PubMed ID: 2040166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.